Our analysis was confirmed by the results obtained in other solid tumors such as HNSCC and melanoma, in which sLAG3 appeared to identify patients with a worse prognosis or resistance to treatment [25, 26]. This evidence concerns the gene LAG3 and head and neck squamous cell carcinoma.